Cutaneous Squamous Cell Carcinoma Updates in Staging and Management
Cutaneous Squamous Cell Carcinoma Updates in Staging and Management
复制标题
DOI：
10.1016/j.det.2019.03.009
复制
发表时间：
2019-07-01
影响因子：
2.4
通讯作者：
Lee, Erica H.
中科院分区：
文献类型：
--
作者：
Bander, Thomas S.;Nehal, Kishwer S.;Lee, Erica H.
皮肤鳞状细胞癌（cSCC）是美国最常见的癌症之一。结果通常是有利的，但cSCC的一个子集是生物学上不同的，需要不同的方法，因为它的局部复发，转移和死亡的风险较高。本文重点介绍了最近的文献，关于确定这一高风险的子集，努力验证和提高分期系统的预后能力，并更新管理。
Cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the United States. Outcomes are generally favorable, but a subset of cSCC is bio-logically distinct and requires a different approach because of its higher risk of local recurrence, metastasis, and death. This article focuses on the recent literature regarding identification of this high-risk subset, efforts to validate and improve the prognostic ability of staging systems, and updates in management.